Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malaria

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 105 articles: HTML format

Single Articles

June 2026
1. BEDSAUL-FRYER JR, Mbulaiteye SM
   Selective Immune Tolerance: A Unifying Mechanism Linking Heavy Malaria Exposure, Waning Vaccine Antibodies, and Burkitt Lymphoma.
   J Infect Dis. 2026 Jun 18:jiag312. doi: 10.1093.
   PubMed    
   
   
   
2. MARQUART-WILSON L, Alkema M, Collins K, Lanke K, et al
   Characterising the circulation of gametocytes and mosquito infectivity in induced blood stage malaria.
   J Infect Dis. 2026 Jun 17:jiag301. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. PUCA MCSB, Mascarenhas MEP, Huguet QB, Salazar YEAR, et al
   Hidden Infections, Emerging Resistance: Underdiagnosed Plasmodium vivax and Multidrug Resistance-1 (pvmdr1) Gene Amplification in the Guiana Shield.
   J Infect Dis. 2026;233:e1480-e1489.
   PubMed     Abstract available
   
   
   May 2026
4. TRAVASSOS MA, Han P, Coulibaly D, Stucke EM, et al
   Distinct Plasmodium falciparum Erythrocyte Membrane Protein 1 Domain Cassette-Associated Antibody Gaps Specific to Cerebral Malaria and Severe Malarial Anemia.
   J Infect Dis. 2026 May 27:jiag256. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. WANNIGAMA DL, Amarasiri M, Phattharapornjaroen P, Hurst C, et al
   Tracking Plasmodium knowlesi Through Fecal DNA for Monitoring Zoonotic Transmission in Wild Macaques Across Southeast and South Asia.
   J Infect Dis. 2026;233:e1238-e1243.
   PubMed     Abstract available
   
   
   
6. RAI A, Sutanto E, Ghimire P, Wangchuk S, et al
   Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.
   J Infect Dis. 2026 May 15:jiag268. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. CHENG WT, Fogang B, Jain A, Davies DH, et al
   Infants under 24 months with severe malaria have a serological profile of active infection with Epstein Barr Virus.
   J Infect Dis. 2026 May 15:jiag264. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. SBARRA AN, Stone W, Tetteh K, Ssewanyana I, et al
   Assessing the effect of malaria exposure history on tetanus antibody waning rates among children in Jinja and Tororo Districts, Uganda.
   J Infect Dis. 2026 May 9:jiag255. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2026
9. WILBURN L, Bui HL, Akampurira P, Ddamba R, et al
   Schistosoma mansoni Infections Are Associated With Fecal Calprotectin Markers of Gut Inflammation After Accounting for HIV, Hepatitis B, and Malaria.
   J Infect Dis. 2026 Apr 29:jiag094. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. JARAMILLO-UNDERWOOD A, Ogunniyi A, Zhou H, Uhomoibhi P, et al
    Risk factors and geospatial associations with Plasmodium falciparum malaria infection and IgG seroprevalence: Nigeria, 2018.
    J Infect Dis. 2026 Apr 8:jiag098. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2026
11. HAFIDZAH M, Degaga TS, Christian M, Alam MS, et al
    Predicting risk of Plasmodium vivax microscopy-detected episodes using serological markers in patients with Plasmodium falciparum malaria: a multi-country diagnostic performance evaluation.
    J Infect Dis. 2026 Mar 17:jiag164. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. BARENG APN, Naung MT, Martin E, Mehra S, et al
    Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens.
    J Infect Dis. 2026;233:e745-e755.
    PubMed     Abstract available
    
    
    
13. 
    Correction to: Chemical Targeting of Prolyl-tRNA Synthetase Stalls Ovarian Development and Kills Malaria Vectors.
    J Infect Dis. 2026 Mar 4:jiag120. doi: 10.1093.
    PubMed    
    
    
    February 2026
14. NALUBEGA M, Soon MSF, Andrew D, Ortega-Pajares A, et al
    Comparison of CD4 T cell response in Plasmodium falciparum and vivax malaria.
    J Infect Dis. 2026 Feb 27:jiag115. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. RIGGLE BA, Chamzas A, Gopalakrishnan M, Nyirenda OM, et al
    Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trial.
    J Infect Dis. 2026 Feb 26:jiag121. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. NDIZEYE R, Gunderson AK, Baguma E, Giandomenico DA, et al
    Test Performance of Expired Malaria Rapid Diagnostic Tests: A pilot diagnostic accuracy study conducted in Western Uganda.
    J Infect Dis. 2026 Feb 19:jiag105. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. AUNG PL, Sripoorote P, Petchvijit P, Suk-Aum K, et al
    Spontaneous Clearance of Polymerase Chain Reaction-Positive Plasmodium vivax Parasitemia in Northwestern Thailand: An Epidemiological Perspective.
    J Infect Dis. 2026;233:e501-e509.
    PubMed     Abstract available
    
    
    
18. CONNELLY SV, Muller JG, Ali M, Ngasala BE, et al
    Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023.
    J Infect Dis. 2026;233:e491-e495.
    PubMed     Abstract available
    
    
    
19. KIZZA J, Katairo T, Kakuru A, Nsengimaana B, et al
    Recurrent Plasmodium falciparum parasitemia and drug resistance mutations during intermittent preventive treatment of malaria in pregnancy in Uganda.
    J Infect Dis. 2026 Feb 13:jiag074. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. MWANGI S, Gomes C, Abdi AI, Rodriguez A, et al
    Specific Biomarkers Differentiate Cerebral Malaria from Other Causes of Coma in African children.
    J Infect Dis. 2026 Feb 10:jiag070. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. SAEED M, Aitken EH, Wines BD, Rogerson SJ, et al
    Antibody-dependent neutrophil phagocytosis of Plasmodium falciparum infected erythrocytes is mediated by FcgammaRIIa.
    J Infect Dis. 2026 Feb 5:jiag071. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2026
22. YENGO BN, Ruszin V, Dieng CC, Kipayko C, et al
    Digital PCR Reveals High PvDBP1 but not PvEBP/DBP2 and PvRBP2b Copy Number in Plasmodium vivax From Duffy-Negative Individuals in Central Africa.
    J Infect Dis. 2026;233:164-172.
    PubMed     Abstract available
    
    
    
23. EPSTEIN A, Aramanzan O, Nabende I, Kayondo TM, et al
    Quantifying the role of importation on sustained malaria transmission in a low-to-moderate burden region of Southwest Uganda.
    J Infect Dis. 2026 Jan 6:jiag008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. DIEPPOIS C, Chambonnier G, Gallardo F, Torres M, et al
    A Functional Intronic Variant of LILRB1 Associated with Clinical Malaria in the Senegalese Population.
    J Infect Dis. 2026 Jan 6:jiag007. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2025
25. LIN JT, Mathias DK, Yang G, Loya M, et al
    Uneven Plasmodium falciparum transmission and cryptic ovale transmission from the asymptomatic reservoir in Bagamoyo, Tanzania.
    J Infect Dis. 2025 Dec 13:jiaf634. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. SHANTI PAI, Alexander K, Candrawati F, Andries B, et al
    Chronic malaria is associated with trauma-related splenic rupture requiring splenectomy.
    J Infect Dis. 2025 Dec 11:jiaf629. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2025
27. CASSIDY CA, Shook-Sa BE, Boyce RM, Ciccone EJ, et al
    False-positive malaria rapid diagnostic tests are prevalent among children under 5 years of age in Uganda.
    J Infect Dis. 2025 Nov 28:jiaf604. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. PRETE CA JR, de Sousa TN, Naziazeno IM, Puca MCSB, et al
    How Duffy blood group (FY) polymorphism and age modulate vivax malaria risk at the community level: a population-based retrospective cohort study in the Amazon.
    J Infect Dis. 2025 Nov 6:jiaf562. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
29. CAO Y, Hayashi CTH, Tripathi AK, Takashima E, et al
    Pfs230 Domains 7-10 encoded by DNA vaccines induce potent complement-independent transmission-blocking antibody against Plasmodium falciparum.
    J Infect Dis. 2025 Oct 31:jiaf555. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. MISCHLINGER J, Pechmann K, Werner J, Zinsou AH, et al
    Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trial.
    J Infect Dis. 2025 Oct 29:jiaf544. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. PUCA MCSB, Naziazeno IM, Santos VCFD, Rodrigues PT, et al
    How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil.
    J Infect Dis. 2025;232:e571-e579.
    PubMed     Abstract available
    
    
    September 2025
32. CAREY-EWEND K, Marten A, Muller J, Peter EE, et al
    Seasonal variation and interspecies dynamics among Plasmodium falciparum and ovale species in Bagamoyo, Tanzania.
    J Infect Dis. 2025 Sep 30:jiaf498. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. JOOF F, Hu R, Seydel KB, Cohee LM, et al
    Febrile temperature augments ring-stage Plasmodium falciparum adhesion to brain endothelial cells.
    J Infect Dis. 2025 Sep 10:jiaf474. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. DE ALBUQUERQUE NRM, Corder RM, Johansen IC, Ladeia WA, et al
    The source-sink dynamics of Plasmodium vivax may undermine malaria elimination efforts in the Amazon: an epidemiological and population genomic study.
    J Infect Dis. 2025 Sep 4:jiaf457. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
35. FRIEDMAN-KLABANOFF DJ, Jensen TL, Gelber CE, Pinapati RS, et al
    Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protection.
    J Infect Dis. 2025 Aug 19:jiaf391. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. JATT LP, Gillespie KM, Van P, Hoffman SL, et al
    Manuscript title: Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial with Controlled Human Malaria Infection.
    J Infect Dis. 2025 Aug 14:jiaf435. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. CHUANG YM, Ledizet M, Mattessich M, Fikrig E, et al
    A multivalent peptide vaccine against malaria, targeting Plasmodium CSP and mosquito AgTRIO.
    J Infect Dis. 2025 Aug 13:jiaf432. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. SAMANDARI T, Achola M, Hutter JN, Mboya G, et al
    Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
    J Infect Dis. 2025 Aug 2:jiaf398. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
39. SAEED M, Aitken EH, Naung MT, Bourke C, et al
    Association of a novel IgG3 allele with malaria in children from the Sepik region of Papua New Guinea.
    J Infect Dis. 2025 Jul 25:jiaf390. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
40. SSUUNA C, Mishra H, Hawkes MT, Stefanova V, et al
    Elevated suPAR levels, organ dysfunction and death in children hospitalized with malaria: considerations for use as a risk stratification tool.
    J Infect Dis. 2025 Jun 17:jiaf327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. SONG Y, Deng B, Long CA, Li Q, et al
    Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte Extract.
    J Infect Dis. 2025 Jun 12:jiaf318. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. BERTRAN-COBO C, Dumont E, Noordin NR, Lai MY, et al
    Plasmodium knowlesi Infection Is Associated With Elevated Circulating Biomarkers of Brain Injury and Endothelial Activation.
    J Infect Dis. 2025;231:e966-e975.
    PubMed     Abstract available
    
    
    
43. SLAUGHTER MG, Bhumbra S, Mellencamp KA, Namazzi R, et al
    Elevated Levels of PDGF-BB and VEGF Are Associated With a Decreased Risk of Readmission or Death in Children With Severe Malarial Anemia.
    J Infect Dis. 2025;231:1258-1266.
    PubMed     Abstract available
    
    
    May 2025
44. COPELAND NK, Otieno L, Otieno JD, Otieno S, et al
    Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults.
    J Infect Dis. 2025 May 29:jiaf274. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. SARR D, Andrew AK, Shukla AK, Mwalimu S, et al
    Placental Malaria Induces Oxidative Stress in Human Syncytiotrophoblast.
    J Infect Dis. 2025 May 14:jiaf243. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
46. MARTIN AC, Sadler JM, Simkin A, Musonda M, et al
    Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia.
    J Infect Dis. 2025 Apr 17:jiaf188. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. DIEPPOIS C, Adjemout M, Cretin J, Gallardo F, et al
    An Expression Quantitative Trait Locus of Fc Gamma Receptor Genes Is Associated With Antimalarial IgG Responses and Infection Levels in Burkinabe Families.
    J Infect Dis. 2025;231:1008-1019.
    PubMed     Abstract available
    
    
    March 2025
48. FANCONY C, Fortes-Gabriel E, Zage F, Alexiou E, et al
    Artemether-Lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections.
    J Infect Dis. 2025 Mar 26:jiaf155. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. DASS S, Kundu P, Naskar D, Kanjee U, et al
    Miniaturized assay to evaluate Plasmodium cynomolgi and P. knowlesi as models for prioritizing P. vivax vaccine targets.
    J Infect Dis. 2025 Mar 14:jiaf136. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. GOSWAMI R, Manickam Y, Goel JC, Gupta S, et al
    Chemical targeting of prolyl-tRNA synthetase stalls ovarian development and kills malaria vectors.
    J Infect Dis. 2025 Mar 6:jiaf095. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
51. NAMAZZI R, Kazinga C, Lima-Cooper G, Liepmann C, et al
    G6PD deficiency is associated with an increased risk of acute kidney injury independent of hemolytic complications in children with severe malaria.
    J Infect Dis. 2025 Feb 18:jiaf080. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. SCHALLENBERG E, van Loon W, Mbarushimana D, Igiraneza C, et al
    Prevalence of Plasmodium falciparum drug resistance markers pfcrt K76T and pfaat1 S258L in southern Rwanda, 2010 to 2023.
    J Infect Dis. 2025 Feb 12:jiaf068. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. SANCHEZ JF, Valdivia HO, Pannebaker DL
    Malaria Surveillance: A Cross-sectional Study in the Peruvian Amazon Basin, 2012-2023.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    
54. TAPIA LL, Salas CJ, Sanchez JF, Pannebaker DL, et al
    U.S. NAMRU SOUTH's Insights and Contributions to Diagnostics in the Context of Malaria Elimination.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    
55. WERNSMAN YOUNG N, Gashema P, Giesbrecht D, Munyaneza T, et al
    High Frequency of Artemisinin Partial Resistance Mutations in the Great Lakes Region Revealed Through Rapid Pooled Deep Sequencing.
    J Infect Dis. 2025;231:269-280.
    PubMed     Abstract available
    
    
    
56. KARIUKI SN, Gilchrist JJ, Uyoga S, Macharia A, et al
    Relation Between the Dantu Blood Group Variant and Bacteremia in Kenyan Children: A Population-Based Case-Control Study.
    J Infect Dis. 2025;231:e10-e16.
    PubMed     Abstract available
    
    
    December 2024
57. MARTIN AC, Chaponda M, Muleba M, Lupiya J, et al
    Impact of late rainy season indoor residual spraying on holoendemic malaria transmission: a cohort study in northern Zambia.
    J Infect Dis. 2024 Dec 19:jiae609. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. KAMALIDDIN C, Burke-Gaffney J, Ashraf S, Castaneda-Mogollon D, et al
    A Countrywide Survey of hrp2/3 Deletions and kelch13 Mutations Co-occurrence in Ethiopia.
    J Infect Dis. 2024;230:e1394-e1401.
    PubMed     Abstract available
    
    
    
59. HAGENAH LM, Yeo T, Schindler KA, Jeon JH, et al
    Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance are Infrequent and Impart a Major Fitness Cost.
    J Infect Dis. 2024 Dec 11:jiae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
60. LOPEZ-PEREZ M, Viwami F, Ampomah P, Sustic T, et al
    Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.
    J Infect Dis. 2024 Nov 25:jiae529. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
61. LAPIDUS S, Goheen MM, Sy M, Deme AB, et al
    Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.
    J Infect Dis. 2024 Oct 30:jiae525. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. PESTANA K, Ford A, Rama R, Abagero B, et al
    Copy Number Variations of Plasmodium vivax DBP1, EBP/DBP2, and RBP2b in Ethiopians Who Are Duffy Positive and Duffy Negative.
    J Infect Dis. 2024;230:1004-1012.
    PubMed     Abstract available
    
    
    
63. RATHNAM JTT, Grigg MJ, Dondorp AM, William T, et al
    Reduced red blood cell deformability in vivax malaria.
    J Infect Dis. 2024 Oct 7:jiae490. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
64. TAY MZ, Tang W, Lee WC, Ong ASM, et al
    Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a.
    J Infect Dis. 2024;230:e737-e742.
    PubMed     Abstract available
    
    
    August 2024
65. NAMAZZI R, Mellencamp KA, Opoka RO, Datta D, et al
    Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern Uganda.
    J Infect Dis. 2024 Aug 29:jiae431. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. LAURY JE, Mugittu K, Kajeguka DC, Kamugisha E, et al
    Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022, a single arm clinical trial.
    J Infect Dis. 2024 Aug 26:jiae425. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. TUKWASIBWE S, Garg S, Katairo T, Asua V, et al
    Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda.
    J Infect Dis. 2024;230:497-504.
    PubMed     Abstract available
    
    
    
68. LEE H, Choi Y, Park S
    Obesity, diabetes, Plasmodium infection, and severe malaria in adults: A systematic review and meta-analysis.
    J Infect Dis. 2024 Aug 1:jiae377. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
69. BERNA AZ, Wang XR, Bollinger LB, Banda J, et al
    Breath biomarkers of pediatric malaria: reproducibility and response to antimalarial therapy.
    J Infect Dis. 2024 Jun 17:jiae323. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. JOOF F, Hu R, Saidi A, Seydel KB, et al
    Plasma from older children in Malawi inhibits Plasmodium falciparum binding in 3D brain microvessels.
    J Infect Dis. 2024 Jun 14:jiae315. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
71. RAPP T, Amagai K, Sinai C, Basham C, et al
    Micro-heterogeneity of transmission shapes submicroscopic malaria carriage in coastal Tanzania.
    J Infect Dis. 2024 May 23:jiae276. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. ALI NA, Nema S, Schneider KA, Krishna S, et al
    Low Prevalence of Antimalarial Resistance Mutations in India During 2014-2015: Impact of Combining First-line Therapy With Primaquine.
    J Infect Dis. 2024;229:1574-1583.
    PubMed     Abstract available
    
    
    
73. PERSSON KEM, Horton JL, Kurtovic L, McCarthy JS, et al
    Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.
    J Infect Dis. 2024 May 9:jiae259. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
74. GRAUMANS W, Ayo D, van Lieshout N, Lanke K, et al
    Plasmodium malariae and Plasmodium ovale-Prevalent and Relevant.
    J Infect Dis. 2024;229:1239-1240.
    PubMed    
    
    
    March 2024
75. ADJEMOUT M, Gallardo F, Torres M, Thiam A, et al
    From GWAS to functional variants: ARL14 cis-regulatory variants are associated with severe malaria.
    J Infect Dis. 2024 Mar 26:jiae159. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. WESTERCAMP N, Osei-Tutu L, Schuerman L, Kariuki SK, et al
    Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
    J Infect Dis. 2024 Mar 4:jiae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
77. CAO Y, Hayashi CTH, Kumar N
    A novel ex vivo assay to evaluate functional effectiveness of Plasmodium vivax transmission blocking vaccine using Pvs25 transgenic P. berghei.
    J Infect Dis. 2024 Feb 26:jiae102. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. PRAH DA, Laryea-Akrong E
    Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?
    J Infect Dis. 2024 Feb 13:jiad581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Shriver M, et al
    Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
    J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. FONTOURA PS, Macedo EG, Calil PR, Corder RM, et al
    Changing Clinical Epidemiology of Plasmodium vivax Malaria as Transmission Decreases: Population-Based Prospective Panel Survey in the Brazilian Amazon.
    J Infect Dis. 2024 Feb 7:jiad456. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
81. SCHWAKE CJ, Krueger RM, Hanada T, Chishti AH, et al
    Plasmodium falciparum glutamic acid-rich protein (PfGARP)-independent polyclonal antibodies inhibit malaria parasite growth in human erythrocytes.
    J Infect Dis. 2024 Jan 31:jiae050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. SILVA NI, Souza PFL, Silva BF, Fonseca SG, et al
    Host transcriptional meta-signatures reveal diagnostic biomarkers for Plasmodium falciparum malaria.
    J Infect Dis. 2024 Jan 25:jiae041. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. OLEINIKOV AV, Seidu Z, Oleinikov IV, Tetteh M, et al
    Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian Children With Hemoglobin S and C.
    J Infect Dis. 2024;229:203-213.
    PubMed     Abstract available
    
    
    December 2023
84. MUFUMBA I, Kazinga C, Namazzi R, Opoka RO, et al
    sTREM-1: a biomarker of mortality in severe malaria impacted by acute kidney injury.
    J Infect Dis. 2023 Dec 11:jiad561. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. BARO B, Bassat Q
    sTREM-1 to risk-stratify patients with malaria: A functional crystal ball to improve outcomes and save lifes.
    J Infect Dis. 2023 Dec 11:jiad565. doi: 10.1093.
    PubMed    
    
    
    
86. MALLA P, Wang Z, Brashear A, Yang Z, et al
    Effectiveness of unsupervised primaquine regimen for preventing Plasmodium vivax malaria relapses in northeast Myanmar, a single-arm non-randomized observational study.
    J Infect Dis. 2023 Dec 2:jiad552. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
87. POPKIN HALL ZR, Seth MD, Madebe RA, Budodo R, et al
    Malaria species positivity rates among symptomatic individuals across regions of differing transmission intensities in Mainland Tanzania.
    J Infect Dis. 2023 Nov 22:jiad522. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. ZAYET S, Hagenkotter B, Quadrio I, Gendrin V, et al
    Correspondence on 'Neurofilament light chain as a biomarker of neuronal damage in children with malaria'.
    J Infect Dis. 2023 Nov 9:jiad489. doi: 10.1093.
    PubMed    
    
    
    
89. THONGPOON S, Roobsoong W, Nguitragool W, Chotirat S, et al
    Naturally acquired transmission-blocking immunity against different strains of Plasmodium vivax in a malaria endemic area in Thailand.
    J Infect Dis. 2023 Nov 7:jiad469. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
90. JAIROCE C, Macia D, Torres-Yaguana JP, Mayer L, et al
    RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins.
    J Infect Dis. 2023 Oct 27:jiad471. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. JOSTE V, Colard-Itte E, Guillochon E, Ariey F, et al
    Genetic Profiling of Plasmodium ovale wallikeri Relapses With Microsatellite Markers and Whole-Genome Sequencing.
    J Infect Dis. 2023;228:1089-1098.
    PubMed     Abstract available
    
    
    September 2023
92. ZENO EE, Obala AA, Pence B, Freedman E, et al
    Risk of malaria following untreated sub-patent Plasmodium falciparum infections: Results over 4 years from a cohort in a high transmission area in Western Kenya.
    J Infect Dis. 2023 Sep 15:jiad398. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. TRAORE K, Coulibaly D, Kone AK, Guindo B, et al
    Randomized field trial to assess the safety and efficacy of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in school-aged children in Bandiagara, Mali.
    J Infect Dis. 2023 Sep 8:jiad387. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
94. BALANZA N, Francis CK, Crowley VM, Weckman AM, et al
    Neurofilament light chain as a biomarker of neuronal damage in children with malaria.
    J Infect Dis. 2023 Aug 30:jiad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. XU E, Goel V, Baguma E, Ayebare E, et al
    Evolution of spatial risk of malaria infection after a pragmatic chemoprevention program in response to severe flooding in rural western Uganda.
    J Infect Dis. 2023 Aug 16:jiad348. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. NALWOGA A, Sabourin KR, Miley W, Jackson C, et al
    Plasmodium falciparum malaria is associated with increased KSHV seropositivity and higher KSHV antibody breadth and magnitude: results of a case-control study from rural Uganda.
    J Infect Dis. 2023 Aug 4:jiad308. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
97. SAMAYOA-REYES G, Weigel C, Koech E, Waomba K, et al
    Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.
    J Infect Dis. 2023 Jul 11:jiad264. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
98. BARUA P, Duffy MF, Manning L, Laman M, et al
    Antibody to Plasmodium falciparum variant surface antigens, var gene transcription and ABO blood group in children with severe or uncomplicated malaria.
    J Infect Dis. 2023 Jun 21:jiad217. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
99. ROH ME, Zongo I, Haro A, Huang L, et al
    Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso: a case control study.
    J Infect Dis. 2023 May 23:jiad172. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. SIBLEY CH
     A Breakthrough: Defining Plasmodium vivax Drug Resistance Genes.
     J Infect Dis. 2023;227:1119-1120.
     PubMed    
     
     
     April 2023
101. NZIZA N, Tran TM, DeRiso EA, Dolatshahi S, et al
     Accumulation of Neutrophil Phagocytic Antibody Features Tracks With Naturally Acquired Immunity Against Malaria in Children.
     J Infect Dis. 2023 Apr 26:jiad115. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. CHALLENGER JD, van Beek SW, Ter Heine R, van der Boor SC, et al
     Modelling the impact of a highly potent Plasmodium falciparum transmission-blocking monoclonal antibody in areas of seasonal malaria transmission.
     J Infect Dis. 2023 Apr 12:jiad101. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al
     Building Integrated Testing Programs for Infectious Diseases.
     J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2023
104. BHARDWAJ J, Upadhye A, Gaskin EL, Doumbo S, et al
     Neither the African-centric S47 nor P72 variant of TP53 is associated with reduced risk of febrile malaria in a Malian cohort study.
     J Infect Dis. 2023 Mar 24:jiad066. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2023
105. ANABIRE NG, Quintana MDP, Ofori MF, Hviid L, et al
     The rapid and spontaneous post-partum clearance of Plasmodium falciparum is related to expulsion of the placenta.
     J Infect Dis. 2023 Feb 6:jiad031. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum